These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 21168207

  • 1. Aberrant expression of CKLF-like MARVEL transmembrane member 5 (CMTM5) by promoter methylation in myeloid leukemia.
    Niu J, Li H, Zhang Y, Li J, Xie M, Li L, Qin X, Qin Y, Guo X, Jiang Q, Liu Y, Chen S, Huang X, Han W, Ruan G.
    Leuk Res; 2011 Jun; 35(6):771-6. PubMed ID: 21168207
    [Abstract] [Full Text] [Related]

  • 2. CMTM5 exhibits tumor suppressor activity through promoter methylation in oral squamous cell carcinoma.
    Zhang H, Nan X, Li X, Chen Y, Zhang J, Sun L, Han W, Li T.
    Biochem Biophys Res Commun; 2014 May 02; 447(2):304-10. PubMed ID: 24721428
    [Abstract] [Full Text] [Related]

  • 3. CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines.
    Shao L, Cui Y, Li H, Liu Y, Zhao H, Wang Y, Zhang Y, Ng KM, Han W, Ma D, Tao Q.
    Clin Cancer Res; 2007 Oct 01; 13(19):5756-62. PubMed ID: 17908965
    [Abstract] [Full Text] [Related]

  • 4. CMTM5 induces apoptosis of pancreatic cancer cells and has synergistic effects with TNF-alpha.
    Guo X, Li T, Wang Y, Shao L, Zhang Y, Ma D, Han W.
    Biochem Biophys Res Commun; 2009 Sep 11; 387(1):139-42. PubMed ID: 19577543
    [Abstract] [Full Text] [Related]

  • 5. [Abnormally lower expression of cmtm5 gene in bone marrow cells from patients with multiple myeloma].
    Niu JH, Bao L, Zhang Y, Li JL, Li LD, Xie M, Qin YZ, Lai YY, Jiang Q, Shi HL, Liu YR, Jiang B, Chen SS, Huang XJ, Ruan GR.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr 11; 18(2):363-7. PubMed ID: 20416169
    [Abstract] [Full Text] [Related]

  • 6. Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.
    Campo Dell'Orto M, Banelli B, Giarin E, Accordi B, Trentin L, Romani M, te Kronnie G, Basso G.
    Oncol Rep; 2007 Aug 11; 18(2):417-23. PubMed ID: 17611665
    [Abstract] [Full Text] [Related]

  • 7. [Research advances in CKLF-like MARVEL transmembrane domain containing member 5].
    Yuan YQ, Xiao YB, Liu ZH, Zhang XW, Xu T, Wang XF.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Dec 11; 34(6):625-8. PubMed ID: 23286412
    [Abstract] [Full Text] [Related]

  • 8. Protein tyrosine phosphatase receptor type {gamma} is a functional tumor suppressor gene specifically downregulated in chronic myeloid leukemia.
    Della Peruta M, Martinelli G, Moratti E, Pintani D, Vezzalini M, Mafficini A, Grafone T, Iacobucci I, Soverini S, Murineddu M, Vinante F, Tecchio C, Piras G, Gabbas A, Monne M, Sorio C.
    Cancer Res; 2010 Nov 01; 70(21):8896-906. PubMed ID: 20959494
    [Abstract] [Full Text] [Related]

  • 9. Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia.
    Ruan GR, Qin YZ, Chen SS, Li JL, Ma X, Chang Y, Wang YZ, Fu JY, Liu YR.
    Leuk Res; 2006 Sep 01; 30(9):1159-65. PubMed ID: 16507320
    [Abstract] [Full Text] [Related]

  • 10. Quantification of AML1-ETO fusion transcript as a prognostic indicator in acute myeloid leukemia.
    Yoo SJ, Chi HS, Jang S, Seo EJ, Seo JJ, Lee JH, Park HS, Park CJ.
    Haematologica; 2005 Nov 01; 90(11):1493-501. PubMed ID: 16266896
    [Abstract] [Full Text] [Related]

  • 11. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
    Rusiniak ME, Yu M, Ross DT, Tolhurst EC, Slack JL.
    Cancer Res; 2000 Apr 01; 60(7):1824-9. PubMed ID: 10766166
    [Abstract] [Full Text] [Related]

  • 12. The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia.
    Linggi B, Müller-Tidow C, van de Locht L, Hu M, Nip J, Serve H, Berdel WE, van der Reijden B, Quelle DE, Rowley JD, Cleveland J, Jansen JH, Pandolfi PP, Hiebert SW.
    Nat Med; 2002 Jul 01; 8(7):743-50. PubMed ID: 12091906
    [Abstract] [Full Text] [Related]

  • 13. Repression of vascular endothelial growth factor expression by the runt-related transcription factor 1 in acute myeloid leukemia.
    Ter Elst A, Ma B, Scherpen FJ, de Jonge HJ, Douwes J, Wierenga AT, Schuringa JJ, Kamps WA, de Bont ES.
    Cancer Res; 2011 Apr 01; 71(7):2761-71. PubMed ID: 21447743
    [Abstract] [Full Text] [Related]

  • 14. CMTM5-v1 induces apoptosis in cervical carcinoma cells.
    Shao L, Guo X, Plate M, Li T, Wang Y, Ma D, Han W.
    Biochem Biophys Res Commun; 2009 Feb 20; 379(4):866-71. PubMed ID: 19124004
    [Abstract] [Full Text] [Related]

  • 15. Chromatin accessibility, p300, and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemia.
    Saeed S, Logie C, Francoijs KJ, Frigè G, Romanenghi M, Nielsen FG, Raats L, Shahhoseini M, Huynen M, Altucci L, Minucci S, Martens JH, Stunnenberg HG.
    Blood; 2012 Oct 11; 120(15):3058-68. PubMed ID: 22923494
    [Abstract] [Full Text] [Related]

  • 16. ABL1 promoter methylation can exist independently of BCR-ABL transcription in chronic myeloid leukemia hematopoietic progenitors.
    Sun B, Jiang G, Zaydan MA, La Russa VF, Safah H, Ehrlich M.
    Cancer Res; 2001 Sep 15; 61(18):6931-7. PubMed ID: 11559572
    [Abstract] [Full Text] [Related]

  • 17. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.
    Pabst T, Mueller BU, Harakawa N, Schoch C, Haferlach T, Behre G, Hiddemann W, Zhang DE, Tenen DG.
    Nat Med; 2001 Apr 15; 7(4):444-51. PubMed ID: 11283671
    [Abstract] [Full Text] [Related]

  • 18. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner.
    Elsässer A, Franzen M, Kohlmann A, Weisser M, Schnittger S, Schoch C, Reddy VA, Burel S, Zhang DE, Ueffing M, Tenen DG, Hiddemann W, Behre G.
    Oncogene; 2003 Aug 28; 22(36):5646-57. PubMed ID: 12944913
    [Abstract] [Full Text] [Related]

  • 19. Leukemogenic AML1-ETO fusion protein upregulates expression of connexin 43: the role in AML 1-ETO-induced growth arrest in leukemic cells.
    Li X, Xu YB, Wang Q, Lu Y, Zheng Y, Wang YC, Lübbert M, Zhao KW, Chen GQ.
    J Cell Physiol; 2006 Sep 28; 208(3):594-601. PubMed ID: 16741927
    [Abstract] [Full Text] [Related]

  • 20. High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia.
    Lapillonne H, Renneville A, Auvrignon A, Flamant C, Blaise A, Perot C, Lai JL, Ballerini P, Mazingue F, Fasola S, Dehée A, Bellman F, Adam M, Labopin M, Douay L, Leverger G, Preudhomme C, Landman-Parker J.
    J Clin Oncol; 2006 Apr 01; 24(10):1507-15. PubMed ID: 16575000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.